NEW YORK (GenomeWeb News) – Genetic Technologies today said that the US Patent and Trademark Office has affirmed the validity of certain claims of a primary non-coding DNA patent held by the Australian firm.

In a formal notification to Genetic Technologies, the USPTO states that certain claims of US Patent No. 5,612,179 "are confirmed" while other claims "are not re-examined," Genetic Technologies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.